ACERTA PHARMA

Acerta Pharma, an affiliate of AstraZeneca, is pushing the boundaries of science to redefine care in haematology. By leveraging our scientific platforms to develop and test novel investigational agents designed to directly kill cancer cells or harness the immune system to recognise and eliminate cancer. By addressing blood cancers with high unmet needs, we are advancing our pipeline to enrich first-in-class agents and to deliver best-in-class medicines... Acerta Pharma is a leader in the field of covalent binding technology who is applying this technology to create novel, highly selective therapies for cancer.

Also known as: Acerta Pharma B.V.